Salvo Health

What Salvo Health does

Salvo Health (legal entity: Salvo Studios, Inc.) is a New York-based digital health company founded in 2022 that operates a hybrid AI-enhanced care platform for chronic gastrointestinal and metabolic conditions. The company partners with — rather than replaces — gastroenterology practices, deploying wraparound care that connects patients with cross-functional care teams (registered dietitians, behavioral health specialists, exercise physiologists, and licensed nurses) between in-person clinic visits. Its platform combines Remote Patient Monitoring (RPM), Chronic Care Management (CCM), a proprietary "Whole Self Science" care model that integrates conventional and functional medicine across eight domains (environment, stress, food, sleep, microbiome, movement, relationships, mind-body-gut), and a mobile app delivering personalized care plans, daily habit tracking, care team messaging, and 24/7 support.

The underlying technology stack includes AI-assisted care plan workflows, predictive analytics that reportedly forecast IBD flare-ups weeks in advance, physiological data ingestion from wearable and home medical devices (including Lohman Technologies' HomECG+ at $125 per device), and bidirectional EHR integration that documents adherence data and uploads monthly patient progress summaries to the referring practice. Salvo has extended into metabolic care with dedicated RPM for MASH/MASLD (launched November 2023) and diagnostic testing via Gemelli Biotech partnerships. The company reports 76% of patients improve within four weeks, 79% reduction in GI-related ER visits, 300% increase in provider care efficiency, and per-patient annual savings of $1,889 (IBS) to $2,901 (IBS/IBD).

Salvo generates revenue through a multi-stream model: enterprise platform/usage fees from GI practices, recurring billing through Medicare RPM and CCM codes (patients responsible for the standard 20% Part B copay), and direct patient subscriptions. It has raised approximately $21.6M in cumulative equity across a Seed Prime ($5M, Feb 2024), an expanded Seed Prime ($4M, June 2025), a $4.7M convertible note (2025), and an $8.5M Series A (Jan 2026), from investors including ManchesterStory, City Light Capital, Threshold Ventures, Human Ventures, Felicis, Torch Capital, The Artemis Fund, Owl Capital, Impact X Capital Partners, Contour Venture Partners, and Alumni Ventures. The company reported 800% year-over-year growth in patients and revenue through 2025, with enterprise GI agreements growing over 1,000% and the contracted provider base reaching 801 gastroenterologists — roughly 16% of all independent GIs in the U.S.

Name

Salvo Health

Legal name

Salvo Studios, Inc.

Website

https://salvohealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

51–100 employees

Short description

Salvo Health is a digital health company providing a hybrid AI-enhanced care platform for chronic gastrointestinal and metabolic conditions, partnering with gastroenterology practices to deliver wraparound Remote Patient Monitoring, Chronic Care Management, and multidisciplinary care between in-person visits.

Ownership category

akta.pro rank

Product category

Chronic Care Management

NAICS

Services for the Elderly and Persons with Disabilities (62412)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

akta.pro secondary industries

Home Health Remote Patient Monitoring & Virtual Nursing Providers (HLAFAEAN), Chronic Disease Management & Remote Patient Monitoring (RPM) (HSABACAD)

Keywords

• Chronic care management
• Remote patient monitoring
• Gastroenterology care platform
• Metabolic condition care
• Wraparound care services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Enterprise Platform Fees: B2B subscription or usage-based fees from GI practices and healthcare systems deploying the Salvo Health wraparound care platform. Enterprise agreements with GI doctors generate new revenue streams for practices through RPM billing codes.
2. RPM and CCM Billing: Remote Patient Monitoring and Chronic Care Management services billed to payers. RPM devices and monitoring services generate recurring revenue through healthcare billing codes.
3. Patient Subscriptions: Monthly subscription fees for patient access to the Salvo Health platform and care team services. Subscription continues automatically each month until cancelled.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Salvo Health operates a hybrid AI-enhanced care platform that delivers continuous gastrointestinal and metabolic care between in-person clinic visits. The platform combines remote patient monitoring, chronic care management, a multidisciplinary care team (registered dietitians, behavioral health specialists, exercise physiologists, and licensed nurses), and a patient mobile app, deployed primarily through enterprise partnerships with community GI practices.

Product overview

Salvo Health is a hybrid AI-enhanced care platform for GI and metabolic conditions. The core platform combines Whole Self Science (a proprietary model integrating conventional and functional medicine) with Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) services. These are delivered through a mobile app providing 24/7 access to cross-functional care teams (dietitians, behavioral health specialists, nurses) and integrated with provider EHR systems. Wraparound Care augments in-person GI practice visits with continuous remote support. Add-on modules include specialized RPM programs for MASH/MASLD and diagnostic testing partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Wraparound Care Continuous multidisciplinary care delivery between clinic visits for patients with chronic GI and metabolic conditions, delivered virtually through messaging and monthly video calls by a cross-functional care team.
• Remote Patient Monitoring (RPM) Digital health technology that collects physiological data from patients at home (e.g., via Lohman Technologies HomECG+ device) and transmits it to healthcare providers for evaluation and care plan adjustments.
• Chronic Care Management (CCM) Care coordination and quality improvement service for individuals with multiple chronic conditions lasting 12 months or more, including continuous care team relationships, condition support, and timely health information sharing performed virtually.
• Salvo Health Mobile App Patient-facing mobile application providing 24/7 care team access, daily habit tracking, educational resources, symptom tracking, and personalized care plans for managing chronic GI and metabolic conditions.
• RPM for MASH & MASLD Specialized remote patient monitoring program for MASH/MASLD (fatty liver disease) including monthly nursing visits, dietitian chat access, connected scale for weight monitoring, and tech-enabled lifestyle modification support.
• Diagnostic Testing Partnership (Gemelli Biotech) Partnership-driven offering of advanced diagnostic breath testing for SIBO and ibs-smart IBS blood testing across 29 states, enabling access to specialty diagnostics not generally available in most doctor's offices.

Quantifiable outcome

• 76% of Salvo Health patients report improvement in just 4 weeks
• +7 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Lohman TechnologiescoreTechnology or Integration · 6 March 2026Deepened strategic partnership to expand the use of Lohman's HomECG+ device across multiple states for GI and metabolic conditions. The partnership aims to improve virtual care outcomes through advanced cardiac monitoring technology. Deployment in additional GI clinics in six states planned for 2026.
• Gemelli BiotechcoreTechnology or IntegrationPartnership to offer cutting-edge diagnostic testing for IBS and SIBO across 29 states. Brings advanced breath testing and IBS blood testing not generally available in most doctor's offices, enabling the latest science for better gut health.

Scale indicators11 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Oshi Health: Virtual-first gastroenterology care platform providing multidisciplinary care (dietitians, behavioral health, providers) for chronic GI conditions like IBS and IBD. Most direct competitor to Salvo Health's enterprise B2B2C model with GI practices.
• Vivante Health: Digital GI health platform offering GIThrive, a comprehensive digestive health program combining app-based tracking, dietitian support, and personalized care plans for chronic GI conditions. Direct competitor in employer/payer and provider-channel GI care delivery.
• Ayble Health: Digital digestive health platform combining AI-driven personalized nutrition and behavioral coaching for GI conditions including IBS and IBD. Overlaps with Salvo's GI-focused chronic care model and payer/employer distribution strategy.
• Mahana Therapeutics: Digital therapeutics company focused on IBS and other GI conditions, with FDA-cleared prescription digital therapeutics. Competes with Salvo in delivering evidence-based digital interventions for chronic GI disorders.

Broad incumbents

• Omada Health: Established virtual chronic care platform addressing diabetes, hypertension, and prediabetes with multidisciplinary coaching and RPM. Broader incumbent in chronic disease RPM that could expand into GI over time, applying similar wraparound economics.
• Virta Health: Telehealth platform specializing in metabolic health reversal (type 2 diabetes, prediabetes, obesity) with provider-led nutrition and continuous remote monitoring. Comparable RPM + multidisciplinary care model in adjacent metabolic space.
• Teladoc Health (Livongo): Largest virtual care incumbent with chronic condition management (Chronic Care, Livongo Diabetes, etc.) offerings. Represents the scaled incumbent Salvo could compete with or be acquired by as the GI specialty matures.
• Noom: Consumer digital health platform with metabolic and weight management coaching. Overlaps with Salvo's obesity and metabolic condition offerings and represents a consumer-channel alternative for payer and employer distribution.

Regional players

• Gastro Health: One of the largest gastroenterology practice networks in the U.S. and likely among the 'four largest GI practices' cited as Salvo customers or targets. Comparable GI-specialty customer profile and integrated care delivery infrastructure.

Emerging players

• metaMe Health: Developer of Regulora, an FDA-cleared digital therapeutic for IBS. Niche overlap with Salvo's GI focus and represents a partial competitor in prescription digital therapeutics for chronic GI conditions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/salvohealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salvo Health